ISRG · Intuitive Surgical, Inc.
$452.072026-05-17Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$176
-61.0% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($123 · $212) Analysts Range ($550 · $750) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $5.7B | — | 38.1% | 8.6% | $2.0B | −$713MM | $1.3B | 11.5% | — | 21.1% | $9.4B | $4.73 | — |
| 2022.Q4 | $6.2B | 9.0% | 30.3% | 16.3% | $1.6B | −$1.2B | $392MM | 11.6% | — | 17.0% | $9.1B | $3.67 | — |
| 2023.Q4 | $7.1B | 14.5% | 29.6% | 7.2% | $2.0B | −$2.6B | −$674MM | 11.1% | — | 19.8% | $10.6B | $4.99 | — |
| 2024.Q4 | $8.4B | 17.2% | 33.6% | 12.6% | $2.5B | −$2.1B | $383MM | 11.7% | — | 18.9% | $15.3B | $6.44 | — |
| 2025.Q4 | $10.1B | 20.5% | 35.0% | 13.1% | $3.1B | −$697MM | $2.4B | 12.0% | — | 19.9% | $15.4B | $7.92 | 46.3 |
| italics below = DCF projection · 10yr Rev CAGR: 9.8% |
| 2026.Q4 | $11.5B | +14.4% | 35.4% | 13.8% | $3.5B | −$1.5B | $2.0B | 10.0% | $1.8B | 21.8% | $16.9B | $8.15 | 55.5 |
| 2027.Q4 | $13.1B | +13.8% | 35.4% | 14.5% | $4.0B | −$1.9B | $2.1B | 9.8% | $1.7B | 22.2% | $18.8B | $9.21 | 49.1 |
| 2028.Q4 | $15.0B | +14.2% | 35.4% | 15.2% | $4.5B | −$2.5B | $2.0B | 9.7% | $1.5B | 22.4% | $21.2B | $10.43 | 43.3 |
| 2029.Q4 | $17.2B | +15.1% | 35.4% | 15.9% | $5.1B | −$3.0B | $2.1B | 9.6% | $1.5B | 22.6% | $24.2B | $11.90 | 38.0 |
| 2030.Q4 | $18.9B | +9.7% | 35.4% | 16.6% | $5.6B | −$2.3B | $3.3B | 9.4% | $2.1B | 22.0% | $26.5B | $12.95 | 34.9 |
|
| Term. Yr+ | $26.7B | 4.1% | 25.9% | 20.0% | $5.5B | −$1.5B | $4.1B | 8.6% | $37.1B | 15.5% | — | — | — |
Active scenario IV: $176 (-61.0% vs market)